Value Partners Investments Inc. Lineage Cell Therapeutics, Inc. Transaction History

Value Partners Investments Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$1.21 - $2.48 $181,500 - $372,000	-150,000 Closed	0 $0
Q4 2021 Jan 12, 2022	BUY	$1.84 - $2.68 $55,200 - $80,400	30,000 Added 25.0%	150,000 $366,000
Q2 2021 Jul 30, 2021	BUY	$2.17 - $3.0 $260,400 - $360,000	120,000 New	120,000 $342,000

120

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $84.9M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Value Partners Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Value Partners Investments Inc. with notifications on news.